Skip to main content
. 2013 May 21;13:229. doi: 10.1186/1471-2334-13-229

Table 2.

Cost savings for PCV13 vs. PCV7 pediatric vaccination in normal and pandemic influenza seasons

Influenza scenario IPD Hospitalized pneumonia Non-Hospitalized pneumonia Vaccination Total
Normal season
$ 235 M
$ 509 M
$ 96 M
($ 367 M)
$ 472 M
Pandemic similar to 2009–2010 H1N1 $ 358 M $ 812 M $ 213 M ($ 367 M) $ 1.02 B

IPD, Invasive pneumococcal disease; M, Million; B, Billion.